PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6536407

Developmental flatfoot.

J C D'Amico
View original source ↗Export metadata ↓

Abstract

An overview of the clinical entity referred to as developmental flatfoot has been discussed. Specific reference has been made to its occurrence, etiology, identification, pathomechanics, clinical significance, and management rationale. This often overlooked, inconspicuous condition is the most common musculoskeletal abnormality affecting the foot of the child under 6 years of age. Recognition of the fact that the developmental flatfoot is the logical precursor of foot dysfunction, deformity, and resultant disability later in life will allow the practitioner to design a management program for today that will meet the foot health needs of tomorrow.

Explore related subjects

Biomechanical PhenomenaChildChild, PreschoolFemaleFlatfootFootGaitHumansInfantMaleOrthotic DevicesOsteogenesisShoesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J C D'Amico. 1984. Developmental flatfoot.. https://pubmed.ncbi.nlm.nih.gov/6536407/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets.

We have studied the mechanism of interaction between soluble von Willebrand factor (vWF), labeled with fluorescein isothiocyanate (FITC), and platelets exposed to shear in a cone-and-plate viscometer. A flow cytometer calibrated with fluorescent bead standards was used to calculate the number of molecules associated with each platelet in suspension. To validate the methods and reagents used, binding of the same labeled vWF was assessed in the presence of ristocetin or alpha-thrombin and found to be saturable, with a narrow and symmetric distribution on > 90% of the platelets. As expected, essentially all bound ligand interacted exclusively with platelet membrane glycoprotein (GP) Ib alpha in the presence of ristocetin and with GP IIb-IIIa after stimulation with alpha-thrombin. In contrast, only a minor proportion (< 20%) of the platelets exposed to shear were found to bind vWF, with no evidence for saturation and markedly decreased interaction when the platelet count was below 100,000 microliters. Moreover, shear-induced vWF binding was blocked equally effectively by selected monoclonal antibodies against either GP Ib alpha or GP IIb-IIIa or against the respective binding sites in vWF. Thus, both receptors are involved in the process, possibly through initial transient interactions mediated by GP Ib alpha that lead to platelet activation and subsequent irreversible binding supported by GP IIb-IIIa. While the levels of shear stress theoretically applied to platelets in these experiments are above those thought to occur in the normal circulation, our findings demonstrate a unique vWF binding mechanism that is not mimicked by other known modulators and correlates with platelet aggregation. Similar processes may occur in response to lower shear stress when platelets are exposed to thrombogenic surfaces and agonists generated at sites of vascular injury during thrombus formation.

Biomechanical Phenomena↗